Skip to Main Content

Client FlatWing Pharmaceuticals Awarded String of Victories in Patent Suits

July 30, 2019

Related Service:

Intellectual Property 
Client Success

The Patent Trial and Appeal Board (PTAB) handed down a series of Final Written Decisions that gave our client, FlatWing Pharmaceuticals, a string of victories. FlatWing had filed four petitions for inter partes review challenging multiple Anacor Pharmaceuticals patents. In each instance, PTAB returned a decision that invalidated the patent-in-suit. In sum, our team demonstrated that 39 separate claims found in four different patents were “unpatentable as obvious over the cited prior art.”


Marc R. Wezowski

Of Counsel

Don J. Mizerk


Syed Rizvi, Ph.D.

Senior Scientific Advisor